Volume 62, Pages S2-S7 (December 2002)

Slides:



Advertisements
Similar presentations
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Advertisements

Myoung J. Kang, Alistair Ingram, Hao Ly, Kerri Thai, James W. Scholey 
Plasma sodium and hypertension
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Renal manifestations in Fabry disease and therapeutic options
Epidemiology of diabetic nephropathy in Spain
Volume 64, Pages S27-S32 (October 2003)
Francesco Locatelli, Lucia Del Vecchio, Simeone Andrulli, Sara Colzani 
Obesity, inflammation, and kidney disease
Progression of renal failure and hypertensive nephrosclerosis
Volume 63, Pages S88-S90 (June 2003)
The myogenic response in uremic hypertension
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
George A. Kaysen, Burl R. Don
Volume 74, Pages S55-S59 (December 2008)
Volume 64, Pages S46-S51 (October 2003)
Volume 66, Pages S13-S17 (September 2004)
Comorbidity and confounding in end-stage renal disease
Volume 63, Issue 2, Pages (February 2003)
Volume 70, Issue 11, Pages (December 2006)
The epidemiology of chronic kidney disease
Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats  Radoslav Girchev, Angela.
Prevention of renal failure: The Malaysian experience
Study of Heart and Renal Protection (SHARP)
Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation  Chang-de Zhan, Ram K. Sindhu, Nosratola.
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 70, Issue 12, Pages (December 2006)
Volume 62, Issue 1, Pages (July 2002)
New insights in uremic toxins
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
Volume 68, Issue 2, Pages (August 2005)
Impact of gender on the renal response to angiotensin II
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 62, Issue 3, Pages (September 2002)
Microbiology and outcomes of peritonitis in North America
Nephrology in Latin America, with special emphasis on Brazil
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Neurogenic factors and hypertension in renal disease
Volume 54, Pages S36-S40 (December 1998)
Circadian regulation of renal function
Homocysteine, renal function, and risk of cardiovascular disease
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 63, Issue 1, Pages (January 2003)
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Clinical benefits of slowing the progression of renal failure
Volume 67, Pages S3-S9 (January 2005)
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 55, Pages S3-S16 (June 1999)
Volume 68, Issue 5, Pages (November 2005)
Influence of extracellular pH on intracellular pH in arterioles and skeletal muscle of spontaneously hypertensive and Wistar-Kyoto rats  Pauline Wimberger,
Volume 68, Pages S98-S102 (December 2005)
Charles A. Herzog  Kidney International 
Volume 62, Pages S36-S41 (December 2002)
Volume 54, Pages S207-S210 (September 1998)
Does an apple a day put hypertension in play?
The International Pediatric Peritonitis Registry: Starting to walk
Evaluation of the Losartan in Hemodialysis (ELHE) Study
Ralf Dikow, Marcin Adamczak, Daniel Ernesto Henriquez, Eberhard Ritz
Renal vascular disease in the elderly
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Structural remodeling of resistance arteries in uremic hypertension
Volume 54, Pages S112-S119 (December 1998)
Volume 65, Issue 2, Pages (February 2004)
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Eric N Haugen, Anthony J Croatt, Karl A. Nath  Kidney International 
Volume 74, Pages S4-S9 (December 2008)
Presentation transcript:

Volume 62, Pages S2-S7 (December 2002) Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension  Eva Cediel, Beatriz Vázquez-Cruz, Josefa Navarro-Cid, Natalia De Las Heras, David Sanz-Rosa, Victoria Cachofeiro, Vicente Lahera  Kidney International  Volume 62, Pages S2-S7 (December 2002) DOI: 10.1046/j.1523-1755.62.s82.2.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Concentration-dependent increases in perfusion pressure produced by angiotensin II (Ang II) in isolated kidneys from Wistar-Kyoto rats (WKY;A), diabetic WKY (B), spontaneous hypertensive rats (SHR;C), and diabetic SHR (D). Kidney International 2002 62, S2-S7DOI: (10.1046/j.1523-1755.62.s82.2.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Concentration-dependent reductions produced by ifetroban on the increase in perfusion pressure produced by 10-5 mol/L angiotensin II in isolated kidneys from WKY (A), diabetic WKY (B), SHR (C) and diabetic SHR (D). Kidney International 2002 62, S2-S7DOI: (10.1046/j.1523-1755.62.s82.2.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Concentration-dependent reductions produced by PD145065 on the increase in perfusion pressure produced by angiotensin II (10-5 mol/L) in isolated kidneys from WKY (A), diabetic WKY (B), SHR (C) and diabetic SHR (D). Kidney International 2002 62, S2-S7DOI: (10.1046/j.1523-1755.62.s82.2.x) Copyright © 2002 International Society of Nephrology Terms and Conditions